Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • sanush
    Member
    • Nov 2009
    • 14

    #1

    Tag counts for RNA seq experiment

    Hi all
    We have to design an experiment to sequence the transcriptomes of 2 different cell types to know what genes are differentially expressed.

    ABI recommends different Tag numbers (mappable reads) for different applications but they don't specify the exact (atleast approximate) mappable reads required to survey for different applications.

    So to study the differentially expressed genes in different cell types what is the recommended mappable reads or tags we need to get a good coverage.

    Thanks for the suggestions
  • pmiguel
    Senior Member
    • Aug 2008
    • 2328

    #2
    Originally posted by sanush View Post
    Hi all
    We have to design an experiment to sequence the transcriptomes of 2 different cell types to know what genes are differentially expressed.

    ABI recommends different Tag numbers (mappable reads) for different applications but they don't specify the exact (atleast approximate) mappable reads required to survey for different applications.

    So to study the differentially expressed genes in different cell types what is the recommended mappable reads or tags we need to get a good coverage.

    Thanks for the suggestions
    In case you missed my answer in the other thread you started:

    http://seqanswers.com/forums/showpos...53&postcount=7

    Here is what I posted:

    Brian Coullahan, Lifetech Application Specialist, gave a talk at the 2009 SOLiD Summit in September. He recommended:

    SREK 10-20 million mapped reads
    SWTAK 10-100 million
    SOLiD SAGE 2-5 million
    --
    Phillip

    Comment

    • sanush
      Member
      • Nov 2009
      • 14

      #3
      Thanks Phillip
      I have that slide too, but it gives us a range 10 - 100 M. Is there any specifics like the number of mappable reads required for different applications... what difference can we see in final data with lower reads and higher reads.

      My question is should we have to aim for higher reads(90M) or around 30-40M reads, because as we go for high reads then we need to load 1 sample in multiple segments in quad slide which could increase the cost of the experiment.

      Really appreciate your suggestion

      Subu

      Comment

      • pmiguel
        Senior Member
        • Aug 2008
        • 2328

        #4
        Originally posted by sanush View Post
        Thanks Phillip
        I have that slide too, but it gives us a range 10 - 100 M. Is there any specifics like the number of mappable reads required for different applications... what difference can we see in final data with lower reads and higher reads.

        My question is should we have to aim for higher reads(90M) or around 30-40M reads, because as we go for high reads then we need to load 1 sample in multiple segments in quad slide which could increase the cost of the experiment.

        Really appreciate your suggestion

        Subu
        It is hard to say.
        For polyA+ RNA 30M should be plenty unless you are focused on transcripts with low relative abundance (below, say, 10 transcripts per million), I would think. For non-polyA+ RNA (eg, ribominus) for which you also need information on poly-adenylated messages--then maybe you would want to get closer to 100M because structural RNAs will occupy a large proportion of your sequence space.

        You can always add more sequence later if you don't have enough.

        --
        Phillip

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:13 AM
        0 responses
        16 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, Yesterday, 10:48 AM
        0 responses
        17 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        35 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...